Deutsche Bank Maintains Hold on Harmony Biosciences Hldgs, Raises Price Target to $36
Deutsche Bank analyst David Hoang maintains Harmony Biosciences Hldgs (NASDAQ: HRMY ) with a Hold and raises the price target from $30 to $36.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.